Azithromycin

产品说明书

Print
Chemical Structure| 83905-01-5 同义名 : 阿奇霉素 ;CP 62993; CP 62,993; Z-Pak
CAS号 : 83905-01-5
货号 : A175409
分子式 : C38H72N2O12
纯度 : 98%
分子量 : 748.98
MDL号 : MFCD00873574
存储条件:

Pure form Sealed in dry,2-8°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:
生物活性
描述 Azithromycin, at a concentration of 2 µM, enhances rhinovirus-induced IFNβ expression in primary bronchial epithelial cells from individuals with asthma. This effect is tied to the upregulation of RIG-I like receptors and suppression of viral replication. The knockdown of MDA5, but not RIG-I, reduces the azithromycin-enhanced viral-induced IFNβ expression in these cells[1]. Azithromycin also specifically lowers MMP-9 mRNA and protein levels without influencing NF-κB activity in endotoxin-challenged monocytic THP-1 cells[2].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT03682653 Childhood Mortality Phase 4 Not yet recruiting February 2022 -
NCT00865670 Infection Phase 1 Completed - -
NCT02344628 Yaws Phase 3 Completed - Ghana ... 展开 >> School Based Recruitment Ayensuanor District, Eastern Region, Ghana School Based Recruitment Upper West Akyem, Eastern Region, Ghana School Based Recruitment West Akyem District, Eastern Region, Ghana School Based Recruitment Nkwanta North District, Volta Region, Ghana Papua New Guinea Community Based Recruitment Karkar District, Madang Province, Papua New Guinea Community Based Recruitment Kavieng Subdistrict, New Ireland Province, Papua New Guinea United Kingdom London School of Hygiene and Tropical Medicine London, United Kingdom, WC1E 7HT 收起 <<
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

1.34mL

0.27mL

0.13mL

6.68mL

1.34mL

0.67mL

13.35mL

2.67mL

1.34mL

参考文献

[1]Menzel M, et al. Azithromycin augments rhinovirus-induced IFNβ via cytosolic MDA5 in experimental models of asthma exacerbation. Oncotarget. 2017 Mar 18.

[2]Vandooren J, et al. Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study. PLoS One. 2017 Apr 3;12(4):e0174853.